Table 3.
Reexamination Variables Between the Groups
| Parameters | PVR Group | Medication Group | P Value |
|---|---|---|---|
| CMR | |||
| PRF, % | 2.10 (6.43) | 43.32±8.15 | 0.000 |
| Corrected RV EF, % | 37.94±9.49 | 22.87±9.21 | 0.000 |
| LV EF, % | 54.22±6.75 | 45.67±11.43 | 0.017 |
| RV EDVI, mL/m2 | 104.05±29.04 | 142.50 (69.3) | 0.000 |
| RV ESVI, mL/m2 | 57.82 (34.92) | 94.40 (73.97) | 0.000 |
| RV EDD, mm | 34.00 (9.00) | 48.00 (12.75) | 0.000 |
| TTE | |||
| LV EF, % | 64.49±7.40 | 62.50 (15.95) | 0.384 |
| RV EDD, mm | 27.00 (6.50) | 30.00 (8.75) | 0.031 |
| TR | 1.08±0.89 | 2.74±1.87 | 0.000 |
| ECG | |||
| QRS duration, ms | 138.37±31.76 | 150.67±32.08 | 0.144 |
| Chest x‐ray | |||
| Cardiothoracic ratio | 0.53±0.07 | 0.58±0.06 | 0.008 |
CMR indicates cardiac magnetic resonance; EDD, end‐diastolic diameter; EDVI, end‐diastolic volume index; EF, ejection fraction; ESVI, end‐systolic volume index; LV, left ventricular; PRF, pulmonary regurgitation fraction; RV, right ventricular; TR, tricuspid regurgitation; TTE, Transthoracic echocardiography.